| |
FREE TO CHOOSE MEDICINE
Work is underway to introduce in Congress a Free To Choose Medicine bill. It would empower patients, advised by their doctors, to make informed decisions on the use of not-yet-FDA-approved drugs in late stage clinical testing.
Click here for my working paper that describes how Free To Choose Medicine would lead to enormous shared value between patients and pharmaceutical companies.
See the Heartland Institute's website www.freetochoosemedicine.com.
For a PBS TV interview with Jim Doti, President of Chapman University, click here (Part 1) and here (Part 2).
For a tie-in of Free To Choose Medicine with Andy Grove’s Science editorial about a fundamental rethinking of clinical trials, click here and here. |
|
LATEST PAPER
My latest paper, “Management’s Worldview: Four Critical Points About Reality, Language, And Knowledge Building To Improve Firm Performance,” is available at http://ssrn.com/abstract=1926423.
For a complete list of my downloadable Social Science Research Network papers, see http://ssrn.com/author=386886. |
| |
|
WEALTH CREATION
Click here for the dust jacket, including endorsements, for my new book Wealth Creation: A Systems Mindset for Building and Investing in Businesses for the Long Term.
I have been presenting a book overview to business/finance students who can download my Powerpoint presentation at http://ssrn.com/abstract=1557724 . The core ideas in the book are addressed with the initial 13 slides. The remaining 29 slides address technical valuation issues that constitute a well grounded alternative to mainstream finance thinking.
I have also had good response to a working paper (click here) that presents new angles about how knowledge building and wealth creation are opposite sides of the same coin. |
| |
| September 2011 |
The concept of a Tradeoff Evaluation Database, central to the operation of Free To Choose Medicine, was strongly supported in a Science editorial (click here) by Andy Grove, ex-CEO of Intel. See also comments on this editorial by Alex Tabarrok (click here). |
| |
|
| September 2011 |
My working paper, Management’s Worldview: Four Critical Points About Reality, Language, And Knowledge Building To Improve Firm Performance,” is available at http://ssrn.com/abstract=1926423. |
| |
|
| June 2011 |
My working paper, "Shared Value for Patients and Pharmaceutical Companies," is available at http://ssrn.com/abstract=1868610.
|
| |
|
| April 2011 |
My working paper, "Management's Knowing Process and the Theory of Constraints," is available at http://ssrn.com/abstract=1806500. |
| |
|
| August 2010 |
Click here for a book endorsement of mine that addresses Perceptual Control Theory (PCT). |
| |
|
| July 2010 |
For an upcoming finance conference, I'll present eight figures (click here) that
summarize the key points of my presentation "Life-Cycle Valuation Model - Lessons Learned from a Commercial Research Program, 1970 to 2010." |
| |
|
| November 2009 |
Working paper, "Applying a Systems Mindset to FDA," was published in Medical Hypotheses 72 (2009) 116-120. New title: "A Dual Track System to Give More-Rapid Access to New Drugs: Applying a Systems Mindset to the US Food and Drug Administration (FDA)." This article provides a comprehensive argument for the introduction of consumer choice and competition and pinpoints the weakness in the status quo position. |
| |
|
November 2008 |
Foreward to a new book by David Holland and Tom Larsen, Beyond Earnings: A User's Guide to Excess Return Models and the HOLT CFROI ® Framework
Interview with Vernon Smith about experimental economics and Dual Tracking
The following language versions of the Heartland Institute booklet More Choices, Better Health — Free to Choose Experimental Drugs are being used by free-market think tanks to promote the Dual Tracking proposal:
English, French, Swedish, Japanese, Chinese, Lithuanian |
| |
|
September 2008 |
“Shareholder Value Reviews,” published in Strategic Finance, 2008 . It provides a short and useful overview of the SVR concept.... Read more |
| |
|
| July 2008 |
"Applying a Systems Mindset to Stock Valuation" reviews five important choices that guided the development of the life-cycle valuation model over the last 40 years. This was later published as a chapter in Valuation Handbook, Rawley Thomas and Benton E Gup, editors. |
| |
|
| May 2008 |
"Guidepost to Wealth Creation: Value-Relevant Track Records" was published in the Fall/Winter 2007 issue of the Journal of Applied Finance . |
| |
|
| January 2008 |
"Economic Rewards of Dual Tracking" |
| |
|
| November 2007 |
What exactly are the wealth creation principles believed by Clinton, Obama and Edwards? ... Read more |
| |
|
June 2007 |
Recent experience shows the importance of first making an emotional connection with people before promoting the logic of economic ideas. In this case, freedom to make an informed choice on the use of late-stage experimental drugs ... Read more |
| |
|
May 2007 |
A Spotlight on Atlas Friend and Supporter, Bart Madden |
| |
|
March 2007 |
The Heartland Institute plans a major campaign to promote the ideas described in my booklet "More Choices, Better Health - Free to Choose Experimental Drugs." The first steps will include:
- 24,000 booklets to be mailed in the U.S. , including all elected state and federal officials and those in the news media who focus on health care
- 10,000 booklets to be mailed to influential leaders worldwide
- electronic files of translations of the booklet will be made available
|
| |
|
December 2006 |
Newspaper article was published that described the historical significance of our 1885 Victorian house. |
| |
|
November 2006 |
Highlights of personal correspondence with Milton Friedman that provide insights into his methodology of positive economics.
My paper, For Better Corporate Governance, The Shareholder Value Review has been accepted for publication in the Winter 2007 issue of the Journal of Applied Corporate Finance . |
| |
|
| December 2005 |
"A Clinical Trial for the FDA's Clinical Trial Process"
Published in Cancer Biotherapy & Radiopharmaceuticals |
| |
|
| September 2005 |
Download monograph Maximizing Shareholder Value And The Greater Good . Here is a Book review . Print versions of the monograph can be purchased on Amazon .The CFROI computation used in this monograph is based on more advanced thinking on certain technical issues compared to my 1999 book CFROI Valuation - A Total System Approach to Valuing the Firm.
The above monograph contains more advanced thinking on certain technical issues compared to my 1999 book CFROI Valuation - A Total System Approach to Valuing The Firm. The current CFROI computation excludes acquisition goodwill (see "Will Your Next Acquisition Pay Off?") and capitalizes R&D |
| |
|
| March 2005 |
"A New SEC Mind-Set" |
| |
|
September 2004 |
A short article, "Putting Drugs on a Faster Track," was published in the September 2, 2004 Chicago Tribune . |
| |
|
| June 2004 |
"Breaking the FDA Monopoly" Regulation, Summer, 2004 |
| |
|
| January 1990 |
"A Transactional Approach to Economic Research"
A slightly modified version of this paper was published in The Journal of Socio-Economics , 1991, Vol. 20, No. 1, 57-71. My intention is to post articles written after I retired in November 2003. One exception is this piece since, in my opinion, it is a very useful
summary of the role of the individual in knowledge building. |
| |
|